
Rabu, 31 Oktober 2012
Boehringer Ingelheim
conflicts of interest
deception
fraud
kickbacks
legal settlements
marketing
Just Another Day at the Office: Boehringer Ingelheim Settles Allegations of Deceptive Off-Label Marketing, Kickbacks
Legal settlements by pharmaceutical companies for less than $100 million now seem to barely rate as news in the US. The best report, albeit...